186.74
+5.09(+2.80%)
Currency In USD
| Previous Close | 181.65 |
| Open | 182.63 |
| Day High | 187.76 |
| Day Low | 181.49 |
| 52-Week High | 187.76 |
| 52-Week Low | 93.58 |
| Volume | 115,473 |
| Average Volume | 228,356 |
| Market Cap | 3.66B |
| PE | -46.34 |
| EPS | -4.03 |
| Moving Average 50 Days | 167.43 |
| Moving Average 200 Days | 126.95 |
| Change | 5.09 |
If you invested $1000 in Ligand Pharmaceuticals Incorporated (LGND) 10 years ago, it would be worth $3,362.29 as of October 21, 2025 at a share price of $186.74. Whereas If you bought $1000 worth of Ligand Pharmaceuticals Incorporated (LGND) shares 5 years ago, it would be worth $3,716.25 as of October 21, 2025 at a share price of $186.74.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ligand to Host Investor Day on December 9, 2025
GlobeNewswire Inc.
Oct 16, 2025 11:00 AM GMT
JUPITER, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place in New York City on Tuesday, December 9, 2025 from 10:30 a.m. to 12:00 p.m. Eastern Tim
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
GlobeNewswire Inc.
Oct 09, 2025 11:00 AM GMT
Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payors Lasix ONYU is the 17th Captisol-enabled™ approved product JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharma
Ligand to Participate in September Investor Conferences
GlobeNewswire Inc.
Aug 19, 2025 8:00 PM GMT
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investo